IL17F and acute myeloid leukemia: In the present study, we wanted to find out whether polymorphic variants of the genes coding for IL-17A, IL-17F and receptor for IL-23 (as hallmarks of Th17 cells) could be associated with susceptibility to acute myeloid leukemia, disease progression and/or response to therapy.